15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 22 firms covering Intuitive Surgical Inc, 19 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $375.00 to $685.00, a moderate spread. The average target of $516.71 sits 43% above the current $362.08. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.85 next quarter toward $12.02 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS22 ratings
Strong Buy
Strong Buy00%
Buy1986%
Hold314%
Sell00%
Strong Sell00%
Based on 22 analysts giving stock ratings to Intuitive Surgical Inc.
As of Jul, 19 of 22 firms rate ISRG a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ISRG EPS & revenue forecast
EPS · NEXT QUARTER
$2.85
Range $2.72 – $3.02 · 24 analysts · +13% YoY
Next period, 24 analysts expect Intuitive Surgical Inc to earn $2.85 a share (range $2.72 – $3.02), versus $2.53 a year earlier. Full-year consensus is $10.79, growing to $12.02 the year after.
REVENUE · NEXT QUARTER
$3.2B
Range $3.2B – $3.3B · 24 analysts · +12% YoY
Revenue is expected to reach $3.2B (range $3.2B – $3.3B), +12.1% year-over-year. Full-year consensus is $11.8B, rising to $13.2B next year.
Top analysts covering Intuitive Surgical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ISRG.
#1
Ryan Zimmerman
BTIG
Buy
$469.00+29.5% to target
Coverage
—
+ Follow
#2
Joanne Wuensch
Citigroup
Buy
$500.00+38.1% to target
Coverage
—
+ Follow
#3
Vijay Kumar
Evercore ISI Group
Hold
$375.00+3.6% to target
Coverage
—
+ Follow
#4
Adam Maeder
Piper Sandler
Buy
$470.00+29.8% to target
Coverage
—
+ Follow
#5
Anthony Petrone
Mizuho
Hold
$400.00+10.5% to target
Coverage
—
+ Follow
ISRG stock forecast FAQ
What is ISRG's average 12-month price target?+
The 20 analysts with a live target average $516.71 for Intuitive Surgical Inc over the next 12 months, ranging from a $685.00 high to a $375.00 low.
Is ISRG stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 22 analyst ratings, 19 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ISRG?+
The Street-high target is $685.00 (Bernstein), and the Street-low is $375.00 (Evercore ISI Group). The average of all 20 active targets is $516.71.
How many Wall Street analysts cover ISRG?+
22 analysts have an active rating on Intuitive Surgical Inc, and 20 firms carry a live 12-month price target.
Who is the most accurate analyst covering ISRG?+
Among analysts who currently cover ISRG, Ryan Zimmerman of BTIG has the strongest overall Quantellect track record. Their current call is Buy with a $469.00 target.
What is Intuitive Surgical Inc's projected EPS for next quarter?+
The consensus estimate is $2.85 per share (range $2.72 – $3.02) across 24 analysts. Full-year EPS is projected at $10.79, rising to $12.02 the following year.
How much revenue is Intuitive Surgical Inc expected to report next quarter?+
Consensus revenue is $3.2B (range $3.2B – $3.3B). Full-year revenue is projected at $11.8B, growing to $13.2B next year.
Have analysts been upgrading or downgrading ISRG lately?+
As of Jul, 19 of 22 firms rate ISRG a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ISRG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
BMO Capital
